Clinical trial Recruiting at 1 site Observational Ages 18 and up

IV lidocaine for headaches after non‑traumatic subarachnoid hemorrhage

Official title: Lidocaine Infusion As A Treatment Modality For Headache Following Non-Traumatic Subarachnoid Hemorrhage: A Prospective, Single-Center, Observational Cohort Study

Run by University of Kansas Medical Center · NCT06582810 · Data updated 2026-11-12

This project will try an IV lidocaine infusion to see if it reduces moderate to severe headaches in adults who had a non‑traumatic subarachnoid hemorrhage.

More Headache trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations1 site (Wichita, Kansas)
StatusRecruiting
StartedJanuary 31, 2025
Main results expectedOctober 2027
Study endsJuly 2028
Registry record updatedJuly 10, 2026
Trial IDNCT06582810 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with non‑traumatic subarachnoid hemorrhage who are neurologically stable (Hunt and Hess ≤3), can give numeric pain scores, and have no contraindications to lidocaine.

Probably not a fit

Patients with traumatic subarachnoid hemorrhage, severe neurologic impairment (Hunt and Hess >3), chronic preexisting pain, prior aneurysm, or contraindications to lidocaine are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational project will give adults with non‑traumatic subarachnoid hemorrhage an intravenous lidocaine infusion as part of their headache treatment while collecting data on pain and safety. Patients will report numeric pain scores every two hours while awake for up to seven days, and clinicians will monitor for vasospasm as part of routine care. Inclusion requires age over 18, a Hunt and Hess score of 3 or less, and the ability to communicate pain scores; significant cardiac disease, arrhythmia, seizures, or prior lidocaine allergy exclude participants. The design is non-randomized and descriptive, so results will show safety and pain trends rather than prove definitive causation.

Why it matters

Potential benefit: If successful, IV lidocaine could provide a relatively fast and well-tolerated way to reduce severe post‑SAH headaches and improve patient comfort during recovery.

How similar studies have gone: Applying IV lidocaine to post‑SAH headache is relatively novel—small case reports and limited trials of IV lidocaine for refractory headache suggest possible benefit, but strong evidence in subarachnoid hemorrhage is lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients \> 18 years;
* Have a favorable neurological status defined as Hunt and Hess score ≤ 3 (as it accounts for patient awareness);
* Can communicate numeric pain scores;
* Are diagnosed with non-traumatic subarachnoid hemorrhage

Exclusion Criteria:

* The patient is diagnosed with traumatic subarachnoid hemorrhage;
* If the patient is \< 18 years of age;
* If numeric pain scores could not be captured for \> 3 days of hospitalization;
* If the patient had a prior aneurysm;
* Chronic pain not associated with non-traumatic subarachnoid hemorrhage diagnosis;
* A disability before the stroke (\> 2 on modified Rankin Scale score);
* A Hunt and Hess score \> 3;
* Contraindications to lidocaine (significant cardiac disease, arrhythmia, seizures, previous allergic reaction to lidocaine

Where it's running

  • Ascension Via Christi St. Francis
    Wichita, Kansas, United States
    Recruiting

Study contacts

  • Principal investigator: Fernando Salgado, MD — University of Kansas Medical Center
  • Study coordinator: William L Krogman, MS
  • Email: wkrogman@kumc.edu
  • Phone: 316-268-6156

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.